Under the background of volume procurement and catalog adjustment, the pharmaceutical market book is divided with the text and the car.

Introduction: For the pharmaceutical business, retail pharmacies, auxiliary drugs, health care products and other related subjects, talk about some callous analysis of the point of view.
results of the third batch of drugs in the country have frightened many pharmaceutical practitioners.
of the catalogue is under way and seems to give some people hope of preserving their share of the stock or entering the stock ecology.
, with volume procurement and catalog adjustment will enter the stage of stock reform.
this article, we talk about some callous analysis of pharmaceutical business, retail pharmacies, auxiliary drugs, health care products and other related subjects.
can be sure that these subjects will survive the great health years, but without exception, after a chill.
price should I make for complementary medication? Who is the auxiliary drug? In the author's breakfast experience, soy milk, oil bars, buns are corresponding to the price, but pickles, paper towels are not charged.
is it callous to make such an analogy? Auxiliary medication should not be charged, which is ideal, can also have theoretical support.
, however, it has been suggested that one complementary drug has a nutritional health effect and the other has a certain clinical therapeutic effect.
such a voice brings the problem to the complexity, but also to the substance of further dialectical discussion.
First of all, auxiliary medication and health care products are bounded, which directly determines whether the relevant products can, should not be sold in the hospital, use, we recommend that health care products-type auxiliary drugs "one-size-fits-all" from the hospital, or at least to list the key monitoring list, it is necessary for hospital doctors to give patients informed tips.
second, for the hospital doctors think that there is a certain clinical therapeutic role of auxiliary drugs, of course, not suitable for direct administrative intervention of the coercive measures to be withdrawn.
but the medical reform is relatively thorough and thorough in some areas, some hospitals should make a spontaneous difference.
such as around low-cost drugs, with the purchase of drugs, strengthen clinical treatment path and prescription review control, to recommend standards, the establishment of mechanisms.
Once there is a clearly high price of auxiliary drugs, there is a contradiction in the relationship between price, and obviously has unreasonable use, use of the scene, regardless of whether there is a certain clinical therapeutic role of auxiliary drugs into the regulatory authorities and report the scope of the incident.
price should I have for health care products? Where can I act as a channel? There is no false definition of the price of health care products, if the concept of luxury goods to look at, some health care products prices can be pushed up to sky-high prices, which is not a simple cost audit problem, but the market value of the circulation of the problem.
is not a matter for price regulators, but for consumers.
Of course, the relevant administrative supervision departments and peers report, the public report is still very necessary, have the right to keep an eye on the illegal perpetrators of adultery, such as quality and safety, business qualifications, infringement and embezzlement, economic bribery and other issues.
health care products related practitioners because of the relatively relaxed business environment, can be dynamic design, independent development, for all their decision-making and behavior responsible for planning.
class B over-the-counter drugs is still the category of drugs, but further expansion, is a health care products huge, complex survival competition industry.
this reflects not only the different tracks of health care products and medicines, but also the complex stratified and classified health care products.
Retail pharmacies as a natural partners in health care products, it is bound to deal with two business models of health care products: one is efficiency first, dare to kill prices to enter the market competition for health care products enterprises, products, although not applicable to drug procurement, but related enterprises, products in the pursuit of "quantity price linkage" to the volume of retail pharmacies to bring abundance Pei customers; one is the concept of first, dare to conservatively set a higher price limit unlimited profit-oriented enterprises, products, pharmacies by the drug belt procurement, health insurance personal account reform, medical insurance basic drug strict management and other policies under the pressure, there is every reason, the right to embrace a higher rate of the 1st category of health care products for sale, wish them prosperity.
Retail pharmacies and the pharmaceutical business are facing a difficult time If retail pharmacies bring in the consumption of medicines purchased with a belt, in order to ensure profits, do some price increases (currently generally 15%), may fluctuate around 15% or less in the future.
Because of the increase, the number of drug patients who choose to buy drugs with quantities to retail pharmacies is small, but this reduction in traffic is not related to the health care sector, pharmacies all behavior to be self-destruction.
at a time when health care payment standards have not yet been determined, we are also seeing the urgency of establishing standards for pharmacies to increase the amount of medicines they purchase.
15% is actually a value taken from the head, logically does not match the pharmacy's interests, and technically lacks segmentation categories and model calculations.
increased coverage of on-demand purchases, we foresee the application of this standard to the outflow of prescriptions for hospital-based medicines.
pharmaceutical business in China is not only the distribution of drugs so simple, but also involved in advance capital, control and marketing and other complex, responsible role.
procurement mechanism has ignored the domination of hospitals and pharmacies, and certainly does not regard the pharmaceutical business as an unbreakable fortress.
other words, the era of pharmaceutical business as a bastion of commerce has lost its monopoly advantage as the rear has been drawn from the bottom of the kettle.
in the volume of procurement of strategic procurement services, the pharmaceutical business giant's services have also been collected accordingly.
means that the pharmaceutical business for the distribution of a large quantity of drugs, not allowed to provide less service, also does not allow the private increase in the content of services, the need to provide a standard interface of quality services.
means that pharmaceutical giants have a similar competitive position to local and medium-sized companies in the pharmaceutical business.
Pharma market or ushered in a major wash-up to alleviate external worries in the pharmaceutical business, retail pharmacies, auxiliary drugs, health care products, these with the concept of fast-disappearing between the main body, pharmaceutical e-commerce is an unstoppable, irreversible troublemaker.
Pharmaceutical e-commerce for the pharmaceutical business to bring new competition, new connotation, new efficiency, forcing all to assume the channel, channel status of the pharmaceutical business either expand the monopoly chain, with depth;
The retail pharmacy may become a long-term fragrance, because the retail pharmacy in the aging society, community medical direction in the direction of the existing flow, in the volume of procurement, health care products selection will have a more efficient, more diverse battlefield.
with everyone spitting slot retail pharmacies, while finding that retail pharmacies are not only to make changes to adapt to the times, retail pharmacies "boat small good turn."
the biggest advantage of pharmaceutical e-commerce, pharmaceutical business is nothing more than organizational strength, replication power.
against the background of retail pharmacies constantly showing their own personality, availability and versatility, all pharmaceutical businesses are cause for concern because of the horizontal competition of new forces and the interest game of upstream and downstream.
, including pharmaceutical e-commerce, the pharmaceutical business should be respected only if it provides services and efficiency to the end end.
.